NUVECTIS PHARMA INC (NVCT)

US67080T1088 - Common Stock

10.67 -0.31 (-2.82%)

After market: 10.14 -0.53 (-4.97%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates

		2020	2021	2022	2023	2024	2025	2026
Revenue YoY % growth						N/A
EBITDA YoY % growth		N/A	N/A	N/A -30.28%	N/A -21.62%	N/A 10.67%
EBIT YoY % growth		-10K	-12.89M -128,800.00%	-19.23M -49.19%	-22.897M -19.07%	N/A 13.30%
Operating Margin		N/A	N/A	N/A	N/A	N/A
EPS YoY % growth		N/A	N/A	N/A 58.45%	-1.43 0.48%	N/A 26.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates

	Q4 / 24
EPS Q2Q % growth	-0.26 36.23%
Revenue Q2Q % growth
EBITDA Q2Q % growth	-6.222M 6.15%
EBIT Q2Q % growth	-4.548M 33.76%

All data in USD

Recent Earnings VS Estimates Surprises (USD)

Period	Reported	Estimate	Difference	Surprise
Q3 2024 Q2Q % growth	-0.24 35.14%	-0.26	0.02	6.75%
Q2 2024 Q2Q % growth	-0.26 31.58%	-0.27	0.01	1.96%
Q1 2024 Q2Q % growth	-0.25 7.41%	-0.40	0.15	38.21%
Q4 2023 Q2Q % growth	-0.41 -4.41%	-0.37	-0.04	-10.13%
Q3 2023 Q2Q % growth
Q2 2023 Q2Q % growth
Q1 2023 Q2Q % growth
Q4 2022 Q2Q % growth
Q3 2022 Q2Q % growth
Q2 2022 Q2Q % growth
Q1 2022 Q2Q % growth
Q4 2021 Q2Q % growth
Q2 2021 Q2Q % growth

Recent Revenue VS Estimates Surprises (USD)

Period	Reported	Estimate	Difference	Surprise
Q3 2023 Q2Q % growth
Q2 2023 Q2Q % growth
Q1 2023 Q2Q % growth
Q4 2022 Q2Q % growth
Q3 2022 Q2Q % growth
Q2 2022 Q2Q % growth
Q1 2022 Q2Q % growth
Q4 2021 Q2Q % growth
Q2 2021 Q2Q % growth

EPS and Revenue Revisions

	Next Q (1 month)	Next Q (3 month)	Next Year (1 month)	Next Year (3 month)
EPS	33.42%	33.42%	1.66%	9.82%
Revenue	N/A	N/A	N/A	N/A